We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$339M
AUM Growth
+$46.9M
Cap. Flow
+$46.4M
Cap. Flow %
13.68%
Top 10 Hldgs %
57.14%
Holding
1,272
New
528
Increased
234
Reduced
146
Closed
296

Sector Composition

Rank Sector Weight
1 Communication Services 19.51%
2 Healthcare 17.13%
3 Technology 11.03%
4 Financials 6.4%
5 Industrials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXU
376
DELISTED
Alexco Resource Corp
AXU
$41K 0.01%
+36,000
New +$37.7K
ISD
377
PGIM High Yield Bond Fund
ISD
$419M
$40K 0.01%
2,785
-19,792
-88% -$284K
SILV
378
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$40K 0.01%
+10,000
New +$34.5K
HOME
379
DELISTED
At Home Group Inc.
HOME
$40K 0.01%
+6,143
New +$109K
FNM
380
DELISTED
FANNIE MAE
FNM
$40K 0.01%
15,000
-7,002
-32% -$18.7K
ASH icon
381
Ashland
ASH
$3.45B
$39K 0.01%
500
QQQX icon
382
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.5B
$39K 0.01%
1,782
+220
+14% +$4.92K
SCHH icon
383
Schwab US REIT ETF
SCHH
$11.2B
$39K 0.01%
+1,782
New +$39.8K
PNTR
384
DELISTED
Pointer Telocation Ltd.
PNTR
$39K 0.01%
2,615
+815
+45% +$12.2K
FRE
385
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$39K 0.01%
+15,000
New +$39K
RUSHA icon
386
Rush Enterprises Class A
RUSHA
$6.23B
$38K 0.01%
2,363
+900
+62% +$15.7K
TAK icon
387
Takeda Pharmaceutical
TAK
$56B
$38K 0.01%
2,200
-81,946
-97% -$1.49M
BCS icon
388
Barclays
BCS
$94.3B
$37K 0.01%
5,003
-97,107
-95% -$767K
CARM
389
DELISTED
Carisma Therapeutics
CARM
$37K 0.01%
+1,250
New +$37.4K
RVNC
390
DELISTED
Revance Therapeutics, Inc.
RVNC
$37K 0.01%
+2,901
New +$36.6K
ASLN
391
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$37K 0.01%
303
-370
-55% -$54.7K
CMG icon
392
Chipotle Mexican Grill
CMG
$40.7B
$36K 0.01%
+2,500
New +$35.2K
CSX icon
393
CSX Corp
CSX
$92.8B
$36K 0.01%
+1,398
New +$36K
GAIA icon
394
Gaia
GAIA
$48.1M
$36K 0.01%
4,781
MCR
395
DELISTED
MFS Charter Income Trust
MCR
$36K 0.01%
4,475
-17,078
-79% -$136K
KELYB
396
Kelly Services Class B
KELYB
$792M
$35K 0.01%
1,390
+10
+0.7% +$255
LBRDA icon
397
Liberty Broadband Class A
LBRDA
$5.17B
$35K 0.01%
+344
New +$33.8K
MAR icon
398
Marriott International
MAR
$90.9B
$35K 0.01%
251
-549
-69% -$72.8K
MDLZ icon
399
Mondelez International
MDLZ
$78.5B
$35K 0.01%
+652
New +$33.9K
EVI icon
400
EVI Industries
EVI
$181M
$34K 0.01%
+898
New +$33.2K

Similar funds

FNY Investment Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, FNY Investment Advisers held 1,272 positions worth $339M, up 16% from $292M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

FNY Investment Advisers deployed $46.4M of net new capital in Q2 2019, opening 528 new positions and adding to 234 existing holdings. Its largest new stake was InflaRx: 280,000 shares worth $884K.

By sector, the portfolio is most concentrated in Communication Services at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $21.7M trimmed.

  • FNY Investment Advisers's largest Q2 2019 buy was InflaRx: 280,000 shares worth $884K.
  • FNY Investment Advisers added most to Anadarko Petroleum in Q2 2019, an estimated $46.5M increase.
  • FNY Investment Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $21.7M.
  • FNY Investment Advisers fully exited Coty in Q2 2019, selling an estimated $24.3M.
  • FNY Investment Advisers's ten largest holdings make up 57% of its $339M portfolio in Q2 2019.
  • FNY Investment Advisers opened 528 new positions and closed 296 in Q2 2019.
  • FNY Investment Advisers's portfolio value rose 16% quarter-over-quarter to $339M.

Based on FNY Investment Advisers's 13F filing for Q2 2019, filed 24 Jul 2019.